- Home
- AFJK vs NSPR Comparison
AFJK vs NSPR Comparison
Compare AFJK & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFJK
- NSPR
- Stock Information
- Founded
- AFJK 2023
- NSPR 2005
- Country
- AFJK United States
- NSPR United States
- Employees
- AFJK N/A
- NSPR N/A
- Industry
- AFJK
- NSPR Medical/Dental Instruments
- Sector
- AFJK
- NSPR Health Care
- Exchange
- AFJK NYSE
- NSPR Nasdaq
- Market Cap
- AFJK 68.6M
- NSPR 79.7M
- IPO Year
- AFJK 2023
- NSPR N/A
- Fundamental
- Price
- AFJK $11.14
- NSPR $2.56
- Analyst Decision
- AFJK
- NSPR Strong Buy
- Analyst Count
- AFJK 0
- NSPR 2
- Target Price
- AFJK N/A
- NSPR $4.50
- AVG Volume (30 Days)
- AFJK 14.9K
- NSPR 53.1K
- Earning Date
- AFJK 01-01-0001
- NSPR 05-09-2025
- Dividend Yield
- AFJK N/A
- NSPR N/A
- EPS Growth
- AFJK N/A
- NSPR N/A
- EPS
- AFJK N/A
- NSPR N/A
- Revenue
- AFJK N/A
- NSPR $7,027,000.00
- Revenue This Year
- AFJK N/A
- NSPR $27.41
- Revenue Next Year
- AFJK N/A
- NSPR $127.08
- P/E Ratio
- AFJK $45.11
- NSPR N/A
- Revenue Growth
- AFJK N/A
- NSPR 8.49
- 52 Week Low
- AFJK $10.24
- NSPR $2.07
- 52 Week High
- AFJK $11.20
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- AFJK N/A
- NSPR 54.34
- Support Level
- AFJK N/A
- NSPR $2.42
- Resistance Level
- AFJK N/A
- NSPR $2.60
- Average True Range (ATR)
- AFJK 0.00
- NSPR 0.15
- MACD
- AFJK 0.00
- NSPR 0.03
- Stochastic Oscillator
- AFJK 0.00
- NSPR 75.93
About AFJK AIMEI HEALTH TECHNOLOGY CO LTD
Aimei Health Technology Co Ltd is a blank check company.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.